| INTRODUCTION
Diagnosis of small cell gastrointestinal (GI) lymphoma (LSA) in cats increased six-fold over a four-decade period spanning from 1964 through 2004, highlighting the growing clinical importance of this disease. 1 Frequent identification of the disease continues today, most notably in cats with chronic weight loss, vomiting, decreased appetite and diarrhea. Small cell GI LSA closely resembles feline inflammatory bowel disease (IBD) in its clinical presentation, 2 with both diseases having poorly defined etiologies. Various risk factors including genetic and molecular alterations, [3] [4] [5] diet, 3, 6, 7 and chronic inflammation [8] [9] [10] have been linked to the development of both disorders. Still other studies have suggested an association between chronic mucosal inflammation and the progression of IBD to pronounced dysplasia in the GI tract. [11] [12] [13] [14] Although the microbiota is intimately involved in GI homeostasis and immune balance, several studies in animal models and humans with cancer incriminate bacterial-induced chronic intestinal inflammation as promoting a local environment favorable for malignant transformation, including lymphomagenesis. [11] [12] [13] [14] Increased numbers of mucosal-adherent bacteria were observed in cats with duodenal IBD, 10 while invasive bacteria were observed within blood vessels and serosa of cats with large cell lymphoma. 9 These collective observations suggest that altered microbial composition (e.g. dysbiosis) is associated with development of benign mixed mucosal inflammation (lymphoplasmacytic enteritis with IBD) and GI lymphoid malignancy. 9, 10, [15] [16] [17] [18] Microbial imbalances have also been implicated in the pathogenesis of approximately 20% of all human malignancies, including GI neoplasia such as colorectal adenocarcinomas and gastric carcinomas. [19] [20] [21] Both chronic, high-grade inflammation of disorders such as feline IBD, and lower grade smoldering inflammation attributable to pro-inflammatory bacteria (e.g. Helicobacter spp., Enterobacteriaceae, Fusobacterium spp.) might drive a tumor-permissive milieu characterized by mucosal infiltration with specialized effector cells, including CD11b + myeloid cell derived macrophages, as observed in humans, and rodent models. 9, 19, 21, 22 Differentiated CD11b + myeloid cells play an important role in tumor progression and angiogenesis in rodent models and humans with colorectal cancer (CRC). 19, 23 Nuclear factor kappa-light-chainenhancer of activated B cells (NF-κB), a protein complex of transcription factors, is involved in immune regulation, DNA transcription, and pro-inflammatory cytokine and chemokine production. 24 This protein complex is also involved in activation of effector cells through toll-like receptors (TLRs) in response to GI micro-organisms. Dysregulation of the activation of NF-κB can lead to overproduction of proinflammatory cytokines and cell transformation, triggering the development of cancers in humans. [25] [26] [27] We hypothesized that pro-inflammatory bacteria, including Enterobacteriaceae and Fusobacterium spp. are abundant in the intestinal biopsies of cats with small cell GI LSA relative to cats with IBD. An objective of this study was to investigate the potential relationship between mucosal bacteria and the mucosal expression of NF-κB and infiltrating CD11b + immune cells in GI biopsies of cats with small cell GI LSA versus GI biopsies of cats with IBD.
| MATERIALS AND METHODS

| Study Design
This study was a retrospective study involving 3 study centers, VDx 
| Fluorescence in Situ Hybridization (FISH)
Formalin-fixed embedded tissue sections were mounted on glass slides and evaluated by fluorescence in situ hybridization (FISH) as previously described. 8 In brief, paraffin-embedded tissue specimens were deparaffinized using an automated system by passage through xylene (3 x 10 min), 100% alcohol (2 x 5 min), 95% ethanol (5 min) and lastly 70% ethanol (5 min). The slides were next immediately transported in deionized water to the DNA testing laboratory where they were air dried prior to hybridization. FISH probes of interest, 5'-labeled with either Cy-3 or FITC (Fisher Scientific, Pittsburgh, PA)
were reconstituted with DNAse-free water and diluted to a working concentration of 5ng/μL (Table 1) .
For total bacterial counts, Eub338-FITC was used. 28 For other analyses, specific probes targeting Clostridium spp. (Erec482), 29 Bacteroides-Prevotella group (Bacto1080), 30 Fusobacterium spp.
(Fuso0664), 31 Enterobacteriaceae (Ebac1790), 32 Helicobacter spp.
(Hel717), 33 and Faecalibacterium spp. (Faecali698), 34 were labeled with Cy-3 and were applied simultaneously with the universal bacterial probe Eub338-FITC. This probe array was selected to identify specific bacterial groups and individual bacterial species previously shown to be relevant in the pathogenesis of intestinal cancers in humans, rodents, and dogs. 9, 14, 19, 22, 23, 27, [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] Tissue sections were bathed in 30μL of DNA-probe-hybridization buffer mix in a hybridization chamber maintained at 54 C overnight (12 hours Finally, isotype controls were used as negative controls to help differentiate eventual non-specific background signal from specific antibody signal, by the use of primary antibodies lacking specificity to the target, but matching the class and type of the primary antibody used in the IHC studies.
For assessment of intestinal NF-κB (p65) and CD11b + cells, the cells were quantified in select compartments of the GI tract biopsies (small intestine: villi, basal crypt area, villus-crypt junction; large intestine: apical crypt area, basal crypt area). All cellular types were evaluated using a light microscope (Carl Zeiss) (Carl Zeiss Jena GmbH, Germany), a × 40 objective, a × 10 eyepiece, and a square eyepiece graticule (10 × 10 squares, having a total area of 62,500 μm 
| Statistical Analysis
Tabular data were organized by probe, organ, mucosal compartment and disease group. Mean, median, standard deviation, minimum, and maximum values were calculated from the absolute bacterial counts.
Normality of data was assessed visually by histograms and Q-Q plots.
If data were not found to be normally distributed, they were logtransformed and reassessed. Median values were compared among groups for significance using the Wilcoxon rank sum test. Analyses were considered significant at P < .05. All graphs were constructed using non-log-transformed, actual raw data.
Associations between bacterial numbers (identified by FISH) and the numbers of CD11b + cells and NF-κB expressing cells were assessed using Spearman's rank correlation and tested for significance. Significance was determined as P < .05. Sample size for enrollment was calculated after consultation with a statistician and was based on the desired power and variability in the number of CD11b + cells and NF-κB expressing cells observed in IBD versus small cell GI LSA feline cohorts. Randomization of 12 cats per group would give a power of 80% to detect differences in expression of CD11b + cells and NF-κB expressing cells between cohorts at the .05 significance level.
All analyses were made using SAS 9.4 (SAS Institute, Cary, NC).
3 | RESULTS
| Final Histopathologic Diagnoses
Fourteen cats were diagnosed with IBD based on histopathologic assessment of the mucosal cellular infiltrate (lymphoplasmacytic) after H&E, immunophenotypic staining and PARR as an adjunct diagnostic in equivocal cases. GI biopsies in 9 of 14 of these cats exhibited a 30% to 60% heterogenous population of small to intermediate lym- 
| Quantification and Spatial Distribution of Mucosal Bacteria Determined by FISH
Only few bacteria were identified as invasive within the intestinal mucosal biopsies. Therefore, bacterial quantification was performed in the 3 other mucosal compartments (free mucus, adherent mucus, attaching to surface epithelia) ( Table 2 ) and separately in adherent mucus (Table 3) , in both the ileal and the colonic biopsies. Gastrointestinal biopsies of cats with small cell GI LSA had significantly increased numbers of total Fusobacterium spp. bacteria in the 3 combined mucosal compartments of the colon (P = .017) compared to GI biopsies of cats with IBD (Table 2) . Total Fusobacteria spp. bacteria in the 3 combined mucosal compartments of ileal biopsies of cats with small cell GI LSA was not statisticaly significanct (P = .059) compared to ileal biopsies of cats with IBD (Table 2 ). Gastrointestinal biopsies of cats with small cell GI LSA had significantly increased numbers of total Fusobacteria spp. bacteria in the adherent mucus compartments of the ileum (P = .046) and colon (P = .016) versus GI biopsies of cats with IBD (Table 3 ). There was a significantly increased number of Bacteroides spp. bacteria in the 3 combined ileal mucosal compartments (P = .034) ( Table 2 ) and in the ileal adherent mucus (P = .036) ( Table 3) The amount of each species of bacteria evaluated were subjectively observed to be more prevalent in the adherent mucus layer versus the free mucus, attached to the surface epithelia, and invasive within the mucosa, including for Fusobacterium spp. and Bacteroides spp. bacteria ( Figure 3 and 4) .
| Number of Mucosal CD11b + Myeloid Cells and NF-κB Expression
Cats with small cell GI LSA had significantly increased numbers of of human Japanese patients with later stage CRC compared to earlier stages. 53 These findings, as well as additional observations in rodent models and humans with CRC suggest that chronic inflammatory disease of the GI tract is a potential risk factor for the development of additional channels for amplified inflammatory processes, aneuploidy, high-grade dysplasia, metaplasia and loss of cellular proliferative checkpoints, all of which are processes that can be appreciated in malignancy. 13, 19, 54, 58, 59 The increased numbers of mucosal Fusobacterium spp. bacteria in GI biopsies of cats with GI LSA relative to GI biopsies of cats with IBD noted in the current study, although possibly just an effect of the GI malignancy, could also be associated with a potential progression from high grade chronic lymphoplasmacytic inflammation to inflammation-mediated lymphoid intestinal cancer.
Although incompletely understood, GI inflammation-mediated progression to cancer development might involve bacterial toxin production, release of alarmins, gut biofilm modification, dysregulation of gut barrier function, suppression of anti-inflammatory mediators and IBD, inflammatory bowel disease cats; LSA, small cell gastrointestinal lymphoma cats. (total = 28 cats; IBD = 14 cats; small cell GI LSA = 14 cats). a Mean Bacteroides spp. bacterial count in ileal biopsies of small cell GI LSA cats significantly higher than in ileal biopsies of cats with IBD (P = .036). b Mean Fusobacterium spp. bacterial count in ileal biopsies of small cell GI LSA cats significantly higher than in ileal biopsies of cats with IBD (P = .046). c Mean Fusobacterium spp. count in colonic biopsies of small cell GI LSA cats significantly higher than in colonic biopsies of cats with IBD (P = .016). Eub338, total bacteria; Erec482, Clostridium spp.; Ebac1790, Enterobacteriaceae; Bacto1080, Bacteroides-Prevotella group; Hel717, Helicobacter spp.; Faecali698, Faecalibacterium spp.; Fuso0664, Fusobacterium spp.. Helicobacter spp. induces host responses influencing risk of oncogenesis, and promotes chronic gut inflammation in humans and mice. 46 In a recent study, FISH showed that the presence of enterohepatic helicobacter was significantly associated with poorly differentiated large intestinal adenocarcinoma in cats. 48 Our results showed no significant difference in Helicobacter spp. bacterial counts in GI biopsies of cats with small cell GI LSA compared to GI biopsies of cats with IBD.
It should be noted that in this study the majority of bacteria evaluated were located in the adherent mucus of the GI biobsies, a finding consistent with a prior study. 10 Less bacteria was appreciated in the free mucus and attaching to the surface epithelium, although still subjectively substantial. In a number of the biopsies there was very minimal to no bacteria appreciated invasively in the mucosa.
Although there is clinical relevance in determining the short and long-term outcomes and response to treatment of the underlying enteropathy in cats with alterations in the GI microbiota, we were unable to fully assess the significance of the relationship of Fusobacterium spp. quantification and outcome due to the variation of treatments and the limitation on follow up for a number of these cats. This is worth assessing in future studies, as in human studies and rodent models, overabundance of Fusobacterium spp. in patients or rodents with CRC does appear to have a correlation with poorer prognostic outcome. 36, 51, 54 There are a number of potential limitations to this study. These would include the retrospective study design using medical records completed by different clinicians and the small population of cats evaluated. As diagnosis of IBD and small cell GI LSA rely as much on prior history as diagnostic findings the authors included, at a minimum, the most pertinent historical findings that would be needed to make these diagnoses in light of findings associated with diagnostic testing performed. The administration of antibiotics that could have affected the microbiota would be another potential limitation. The authors attempted to include cats with no history of antibiotic administration 2 weeks prior to the acquisition of GI biopsies but this information was not always reported in the medical records. Processing, including formalin-fixation and paraffin embedding of the biopsies, might have also played a role in the finding of bacteria contained in the adherent mucus compartment, but this is consistent with a prior study 10 and should not have caused a discrepancy in any 1 cat in the study relative to the study population as a whole.
Another potential limitation was the inability to perform PARR on the formalin-fixed, paraffin embedded tissues of all cats. In conclusion, we showed that Fusobacterium spp. bacteria are increased in the ileum and colon of GI biopsies of cats with small cell GI LSA relative to GI biopsies of cats with IBD. We also showed that increased Fusobacterium spp. bacteria are positively correlated to increased CD11b + and NF-κB expression in neoplastic ileal and colonic biopsies versus ileal and colonic biopsies of cats with lymphoplasmacytic ileitis and colitis (idiopathic IBD). Future studies would be needed to attempt to further clarify whether increased Fusobacterium spp is a consequence of small cell GI LSA in cats or whether it plays a role in the development of the disease.
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